Show simple item record

dc.creatorJiang, Lijingen_US
dc.date.accessioned2012-05-10T14:06:08Z
dc.date.available2012-05-10T14:06:08Z
dc.date.created2010-06-25en_US
dc.date.issued2012-05-10
dc.identifier.otherembryo:127941en_US
dc.identifier.urihttp://hdl.handle.net/10776/2033
dc.description.abstractAdvanced Cell Technology, Inc. (ACT) is a biotechnology company that uses stem cell technology to develop novel therapies in the field of regenerative medicine. Formed in 1994, ACT grew from a small agricultural cloning research facility located in Worcester, Massachusetts, into a multi-locational corporation involved in using both human embryonic stem cells (hESC) and human adult stem cells as well as animal cells for therapeutic innovations. Through its work in developing alternative methods for hESC derivation and its public statements, ACT has also played an active role in stimulating and participating in public debate over stem cell research.en_US
dc.format.mediumtext/xhtmlen_US
dc.language.isoengen_US
dc.publisherArizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia.en_US
dc.relation.ispartofEmbryo Project Encyclopediaen_US
dc.rights© Arizona Board of Regentsen_US
dc.subjectOrganizationen_US
dc.subject.lcshAdvanced Cell Technology (Firm)en_US
dc.subject.meshStem Cellsen_US
dc.titleAdvanced Cell Technology, Inc.en_US
dc.title.alternativeACTen_US
dc.typeTexten_US
dc.rights.licenseLicensed as Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) http://creativecommons.org/licenses/by-nc-sa/3.0/
dc.subject.embryoOrganizationsen_US
dc.subject.embryoReproductionen_US
dc.subject.tagStem cellsen_US
dc.subject.tagRegenerationen_US
dc.description.typeArticlesen_US
dc.date.createdstandard2010-06-25


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record